Medical Grand Rounds

The Medical Grand Rounds are an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Ces conférences scientifiques sont des activités de formation collective agréées conformément au programme de Maintien du certificat du Collège royal des médecins et chirurgiens du Canada.

JEWISH GENERAL HOSPITAL

DEPARTMENT OF MEDICINE
MONDAY MEDICAL GRAND ROUNDS
FEBRUARY 2020
12:30 - 1:30 PM
BLOCK AMPHITHEATRE

*February 3
THIRTY FIRST ANNUAL HUMANIZATION OF CARE AWARENESS PROGRAM ROUNDS
MANAGEMENT OF DIFFICULT ENCOUNTERS WITH PATIENTS AND FAMILIES
Robert Biskin, MDCM, FRCPC, MSc
Assistant Professor of Clinical Psychiatry , McGill University
Jewish General Hospital - Institute of Community and Family Psychiatry
Educational Objectives:
At the end of this lecture participants will be able to:
1. Recognize and understand the origins of some challenging clinical challenges
2. Recognize what is a “personality disorder”
3. Review strategies to help with particular types of behaviors
4. Emphasize how to work effectively as a team in difficult situations
Contact Person: Ms. Belinda Amodio, Administration Coordinator, Humanization of Care Committee, Ext. 29124.

*February 10
I. THE HISTORY OF A MISSED DIAGNOSIS
Anthony Lieu, MD
Chief Medical Resident and Internal Medicine Third Year Medical Resident
McGill University and Jewish General Hospital
Educational Objectives:
1. Review the clinical presentation of disseminated histoplasmosis 
2. Review the clinical presentation of negative culture-infective endocarditis
3. Become familiar with the diagnostic testings for disseminated histoplasmosis
II. ATYPICAL HEMOLYTIC UREMIC SYNDROME
Diana Escobar Olaya, MD
Internal Medicine Second Year Resident
McGill University and Jewish General Hospital
Educational Objectives:
1. Quick approach thrombotic microangiopathies, specifically, atypical hemolytic uremic syndrome
2. Clinical presentation/ genetic abnormalities
3. Treatment
Contact Person: Elise Levinoff, MD, Director, Postgraduate Teaching, Tel. 514-340-8222 poste 24974.


*February 17
QUALITY IMPROVEMENT AND THROMBOSIS: A GENERAL INTERNAL MEDICINE SHIDDUCH
Maral Koolian, MD
Assistant Professor of Medicine, McGill University
Division of Internal Medicine, Jewish General Hospital
Blair Schwartz, MDCM, MHS, FRCPC
Assistant Professor, Department of Medicine, McGill University
Division of General Internal Medicine and Department of Adult Critical Care, Jewish General Hospital
& Vicky Tagalakis, MD, FRCPC, MSc
Associate Professor of Medicine
Director, Division of General Internal Medicine
McGill University
Division of Internal Medicine, and Centre for Clinical Epidemiology of the Lady Davis Institute for Medical Research, Jewish General Hospital
Educational Objectives:
1. To review the application of core quality improvement principles to ameliorate quality of care of patients with venous thromboembolic disease
2. To demonstrate the interplay between QI and Thrombosis expertise
3. To present research done at the Jewish General Hospital in General Internal Medicine combining both of these domains 
Contact Person: Rubin Becker, MD, Chief, Division of Internal Medicine, Tel. 514-340-7596.

ºFebruary 24
EXERCISING THE HEART - SOME POSITIVE “STRESS” FOR A CHANGE
Ann Walling, MD
Associate Professor of Medicine, McGill University
Staff Member, Division of Cardiology, Jewish General Hospital
&Lisa Masse, MSc KIN
Kinesiologist
CIUSSS Centre-Ouest Cardiac Rehabilitation Center
Richardson Hospital
Educational Objectives:
1. Provide an overview of cardiac and non cardiac benefits of exercise
2. Review the impact of delay in starting cardiac rehab enrollment
3. Discuss obstacles to successful cardiac rehab
Contact Person: Lawrence Rudski, MD, Chief, Division of Cardiology and Director, Azrieli Heart Center, Tel. 514-340-8222 ext. 22992.

*Lunch will be served at 12:10 PM. 
ºPlease bring your own lunch on February 24, 2020.

The Medical Grand Rounds are an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

 

JEWISH GENERAL HOSPITAL
DEPARTMENT OF MEDICINE
MONDAY MEDICAL GRAND ROUNDS
JANUARY 2020
12:30 - 1:30 PM
BLOCK AMPHITHEATRE

*January 6
ARE THE TOXICITIES OF CANCER IMMUNE CHECKPOINT INHIBITORS ON YOUR CHECKLIST?
Khashayar Esfahani MD, MSc, FRCPC, FACP
Assistant Professor of Oncology 
Rossy Cancer Network, McGill University
Staff Member, St-Mary's Hospital
Researcher, Lady Davis Institute, Jewish General Hospital
Educational Objectives:
1- A brief overview of recent progress in cancer immunotherapy
2- Optimal diagnosis and management of immune-related adverse events
3- Case-based discussion of critical decision making components
Contact Person: Lawrence Panasci, MD, Division of Oncology, Tel. 514-340-8248.

 

*January 13
BRIDGING THE FACULTY AND CLINICAL "DIVIDES": HOW UGME AND FACULTY DEVELOPMENT WORK TOGETHER TO HELP YOU HELP OUR LEARNERS
Beth-Ann M. Cummings, MD, MSc (Health Professions Education), FRCPC
Associate Dean, Undergraduate Medical Education, Faculty of Medicine
Associate Professor, Department of Medicine
McGill University
Associate Member, Institute of Health Science Education
Division of Internal Medicine, Jewish General Hospital
& Michelle Elizov, MD FRCPC MHPE
Associate Professor of Medicine and Associate Dean, Faculty Development
McGill University
Division of Internal Medicine, Jewish General Hospital
Educational Objectives:

1. To describe educational challenges in DoM from both teacher and learner perspectives

2. To understand how UGME and Faculty Development communicate and collaborate to support teachers

3. To describe best practices in making an educational “diagnosis” and communicating it effectively

Contact Person: Rubin Becker, MD, Chief, Division of Internal Medicine, Tel. 514-340-7596.

 

ºJanuary 20

BUILDING AN INTERDISCIPLINARY INTER-INSTITUTIONAL RESEARCH INITIATIVE: LESSONS LEARNED FROM MI4

Donald Sheppard, MD, FRCPC
Director, McGill Interdisciplinary Initiative in Infection and Immunity 
Chair, Department of Microbiology & Immunology
Professor, Department of Medicine, Microbiology & Immunology
McGill University
Educational Objectives:
1. To review the mission, structure and vision of the McGill Interdisciplinary Initiative in Infection and Immunity (MI4)
2. To learn to identify barriers to collaborative research and discuss strategies to mitigate these challenges
Contact Person: Karl Weiss, MD, Chief, Division of Infectious Diseases, Tel. 514-340-8222 ext. 28294.

ºJanuary 27
INFLAMMATION REDUCTION IN CARDIOVASCULAR DISEASE

Jean-Claude Tardif CM, MD, FRCPC, FCCS, FACC, FAHA, FESC, FCAHS
Director, MHI Research Center
Professor of medicine
Canada Research Chair in translational and personalized medicine
Université de Montréal endowed research chair in atherosclerosis
Montreal Heart Institute
Educational Objectives:
1. Understand the evidence implicating inflammation in atherosclerosis
2. Learn about the trials that have tested inflammation reduction in coronary disease
Contact Person: Lawrence Rudski, MD, Chief, Division of Cardiology and Director, Azrieli Heart Center, Tel. 514-340-8222 ext. 22992.

*Lunch will be served at 12:10 PM. 
ºPlease bring your own lunch on January 20 & 27.

 

The Medical Grand Rounds are an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

HÔPITAL GÉNÉRAL JUIF
DÉPARTEMENT DE MÉDECINE
CONFÉRENCES SCIENTIFIQUES
12H30 - 13H30
SALLE BLOCK AMPHITHÉATRE

 

* Un léger déjeuner sera servi à 12h10.

JEWISH GENERAL HOSPITAL
DEPARTMENT OF MEDICINE
MONDAY MEDICAL GRAND ROUNDS
12:30 - 1:30 PM
BLOCK AMPHITHEATRE

* Lunch will be served at 12:10 PM.

* December 16, 2019

INFLAMMATION AFTER STROKE: A TREATABLE MECHANISM OF COGNITIVE IMPAIRMENT?

Alexander Thiel, MD, PhD

Associate Professor, Department of Neurology and Neurosurgery, McGill University
Director, Comprehensive Stroke Centre, Jewish General Hospital
Director, Neuroplasticity Research Program, Lady Davis Institute for Medical Research

Educational Objectives:

1. To learn the difference between post-stroke cognitive impairment (PSCI) and other forms of age related cognitive decline
2. To learn about the role of neuroinflammation for neurodegeneration after stroke
3. To learn how diabetes and hypertension can modulate brain inflammation
4. To learn about possible treatment strategies

Contact Person: Jeffrey Minuk, MD, Chief, Department of Neurosciences, Tel. 514-340-8222 ext. 28770.

December 9, 2019

NANO-MEDICINE- THE FUTURE IS HERE

Mark Trifiro, MD
Professor of Medicine, McGill University
Chief, Division of Endocrinology, Jewish General Hospital

Educational Objectives:

1. Introduction to nano-particles and role in nano-medicine
2. Treatment of neoplasms in the context of inter tumoral and intra tumoral heterogeneity

Contact Person: Mark Trifiro, MD, Chief, Division of Endocrinology, Tel. 514-340-8222 ext. 23976.

 

* December 2, 2019

THE JOURNEY OF ENDOVASCULAR TREATMENT IN ACUTE STROKE: WHERE ARE WE COMING FROM, WHERE WE ARE NOW, WHERE WE ARE GOING

Daniel Roy, MD, FRCPC

Professor of Radiology, Université de Montréal
Head of the Neuroradiology Division, CHUM

Educational Objectives:

1. To understand the clinical evidence underlying the 2015 revolution in the treatment of acute stroke
2. To appreciate the controversy regarding the imaging-based patient’s selection for thrombectomy
3. To understand the current issues regarding the expansion of indications as well as the implementation of this treatment

Contact Person: Paul Warshawsky, MD, Chief, Department of Adult Critical Care, Tel. 514-340-7500.

September 2, 2019

Labour Day - No Rounds

September 9, 2019

No rounds

September 16, 2019

CLINICAL ETHICS ROUNDS
ETHICAL ISSUES REGARDING PEG FEEDING TUBES FOR DEMENTIA PATIENTS; A CASE REVIEW

Educational Objectives:
1. Engage in a discussion about the risks and benefits of the intervention 
2. Analyze the role of the patient’s substitute decision-maker regarding feeding tube’s 
3. Review of legal components 
 
Mr. Kevin Hayes
Clinical Ethicist 

Albert Cohen, MD
Associate Professor of Medicine, McGill University 
Chief, Division of Gastroenterology, Jewish General Hospital 

Me Andréane Baribeau
Attorney- CIUSSS West Central Montreal 
 

September 23, 2019

THE FUTURE OF PATHOLOGY: FACTS, TRENDS, AND DREAMS 

Educational Objectives:
At the end of the presentation, the attendees will:
1. Be more familiar with the recent and current evolution of Pathology, especially in the field of molecular pathology and contextual genomics
2. Better understand the current and coming disruptive technologies in Pathology
3. Have some ideas on the mid- and long-term direction of medical diagnostics, including Pathology 
 
Alan Spatz, MD 
Professor of Pathology and Oncology, McGill University 
Director, Division of Pathology, Jewish General Hospital
Canada Research Chair in Molecular Pathology  

September 30, 2019

No Rounds - Rosh Hashanah

* October 7, 2019

FIFTH ANNUAL DEPARTMENT OF MEDICINE CLINICAL RESEARCH SYMPOSIUM
I. AN ASSAY TO MEASURE CYP3A4 AND CYP1A2 ENZYME ACTIVITY IN HUMANS: POTENTIAL RELEVANCE IN LUNG CANCER 
Thomas Jagoe, MD, PhD, FRCP

Associate Professor of Medicine, McGill University
Director, McGill Cancer Nutrition Rehabilitation (CNR) Program
Co-Director of Peter Brojde Lung Cancer Centre (PBLCC)
Staff, Division of Pulmonary Medicine
Jewish General Hospital
Educational Objectives:
1. To remind audience about potential clinical importance of CYP3A4 enzyme activity in drug metabolism
2. To outline the theoretical link between activity of CYP3A4 and CYP1A2 enzymes and metabolism of certain anticancer drugs used in lung cancer
3. To detail the range of different factors which can influence activity of these enzyme
II. A MULTIDISCIPLINARY APPROACH TO DOCUMENTATION OF DELIRIUM IN HOSPITALIZED MEDICAL PATIENTS
Elise Levinoff, MD

Assistant Professor of Medicine, McGill University
Staff, Division of Geriatric Medicine, Jewish General Hospital
Educational Objectives: 
1. To assess whether a focused teaching session on delirium in hospitalized medical inpatients can improve documentation 
2. To determine whether the change in documentation leads to better work up and management of delirium in hospitalized inpatients
3. To promote the importance of AAPA (Approche Adaptée à la Personne Âgée) and its relevance to hospitalized medical patients
III. UNUSUAL HOBBIES AND BAD HABITS: MY EXPERIENCE WITH FECAL MICROBIOTA TRANSPLANT AT THE JGH
Marty Teltscher, MDCM, FRCPC 

Medical Lead, JGH Antimicrobial Stewardship Program
Assistant Professor, McGill University Faculty of Medicine
Division of Infectious Diseases, Department of Microbiology
CIUSSS - CO Montréal - West Central Montreal Health
Jewish General Hospital 
Educational Objectives: 
1. What is fecal microbiota transplant, and why is thought to work? 
2. Is there something particular about patients that suffer from recurrent/refractory C. difficile infections?
3. What I have encountered while doing consults for FMT
Contact Person: E. L. Schiffrin, MD, PhD, Physician-in-Chief, Department of Medicine, Tel. 514-340-7538.

October 14, 2019

No Rounds - Thanksgiving

* October 21, 2019

CLEANLINESS AND GODLINESS: REVISITING SKIN HYGIENE AND CUTANEOUS T CELL DYSREGULATION IN ATOPIC DERMATITIS 
Carolyn Jack, MDCM, PhD, FRCPC

Assistant Professor of Medicine, McGill University
Divisional Lead in Quality and Innovation
Division of Dermatology Medicine
St. Mary's Hospital and Jewish General Hospital
McGill University Health Centre 
Educational Objectives: 
1. What is the role of Staphylococcus Aureus in Atopic Disease ?
2. What kind of cells give us immunity at the skin surface?
3. What is the role of soap in skin health? 
Contact Person: Robin Billick, MD, Chief, Division of Dermatology, Tel. 514-340-8222 ext. 25065.

* October 28, 2019

DILEMMAS IN THE CARE OF THE PERSON WITH ADVANCED DEMENTIA
Susan Mitchell, MD, MPH

Professor of Medicine, Harvard Medical School  
Senior Scientist, Hinda and Arthur Marcus Institute for Aging Research
Director, Palliative Care in Aging Research Center
Co-Director of the Interventional Studies in Aging Center
Hebrew Senior Life in Boston 
Educational Objectives: 
1. Understand the clinical course of advanced dementia
2. Gain knowledge regarding the most common complications and management outcomes in advanced dementia
3. Be able to operationalize an ethically sound, evidence based approach to decision-making in advanced dementia 
Contact Person: José Morais, MD, Chief, Division of Geriatric Medicine, Tel. 514-340-7501.

*November 4

RECENT ADVANCES AND NOVEL APPROACHES IN TARGETED THERAPY FOR LUNG CANCER

Carmela Pepe, MD, FRCPC
Assistant Professor of Medicine, McGill University
Division of Pulmonary Diseases, Department of Medicine, Jewish General Hospital

& Jason Agulnik, MD, FRCPC
Assistant Professor of Medicine, McGill University
Division of Pulmonary Diseases, Department of Medicine, Jewish General Hospital

Educational Objectives:
1. Review recent novel therapies in oncogenic driven lung cancer (Dr. Pepe)
2. Review strategies in detection of molecular targets (Dr. Agulnik)
Contact Person: Carmela Pepe, MD, Division of Pulmonary Medicine, Tel. 514-340-8222 ext. 23636.

*November 11

CANADIAN PATIENT SAFETY WEEK

IMPROVING DISCLOSURE IN PERSON CENTERED CARE

Suzanne Levitz, MD
Associate Director of Professional Services (DPS), CIUSSS CODIM

Mrs. Chantal Bellerose
Assistant to the Directorate of Quality, Innovation, Evaluation, Performance and Clinical Ethics (DQIEPE) Coordinating Quality, Risk Management, Accreditation, Clinical Ethics, User Experience and Planetree, CIUSSS CODIM

Me Nathalie Lecoq
Chief Legal Counsel and Coordinator of Legal Affairs
Directorate of Human Resources, Communications and Legal Affairs (DHRCAJ), CIUSSS CODIM

Ms. Isabelle Caron
Associate Nursing Director, CIUSSS CODIM

Mr. Evan Litwin
Patient Partner

Educational Objectives:
1. Reviewing disclosure obligations and data on our current practice
2. Building our skills towards disclosure and continuously improving our culture of caring, learning, improvement and trust
3. Recognizing challenges in documenting and ensuring effective communication to manage events and meet mandatory AH-223 reporting guidelines
4. Ensuring person centered care and services, team work and user-patient-family partnership for success: closing the loop 

Contact Person: Chantal Bellerose, Dt. P., B. Sc., M. Sc. Health Adm., Assistant to DGA -Director, Director DQEPEA and Coordinator of quality, risk management, accreditation, clinical ethics and user experience, ext. 27895.

*November 18

MULTIPLE MYELOMA: 2019 AND BEYOND

Rayan Kaedbey, MD
Assistant Professor of Medicine, McGill University
Member, Division of Hematology, Jewish General Hospital

Educational Objectives:
1.To recognize the updated diagnostic criteria and prognostication strategies
2. To recognize current treatment approaches
3. To understand future directions in testing and therapeutics
Contact Person: Hans Knecht, MD, Chief, Division of Hematology, Tel 514-340-8222 ext. 28799.

*November 25

CAN WE ELIMINATE HEPATITIS C?

Averell Sherker, MD, FRCPC
Scientific Advisor for Viral Hepatitis and Liver Diseases, Division of Digestive Diseases and Nutrition
Adjunct Investigator, Clinical Research Section, Liver Diseases Branch
National Institute of Diabetes and Digestive and Kidney Diseases
Bethesda, Maryland

Educational Objectives:
1. Understand the epidemiology, natural history, and treatment of Hepatitis C
2. Understand strategies for the eradication of Hepatitis C
3. Become aware of ongoing implementation projects worldwide
Contact Person: Polymnia Galiatsatos, MD, Division of Gastroenterology, Tel. 514-340-8222 x 28144.

 

Page last updated on 

We always seek feedback to make our site better.